Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,489,500 | 2,253,200 | 1,055,900 | 5,069,500 | 3,899,900 |
| Depreciation Amortization | 1,054,700 | 696,500 | 340,900 | 1,328,200 | 989,700 |
| Income taxes - deferred | 222,000 | 14,500 | 92,500 | 559,700 | 479,800 |
| Accounts receivable | N/A | N/A | N/A | -319,100 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -363,900 | N/A |
| Other Working Capital | 76,700 | -89,400 | -595,600 | -185,500 | -820,300 |
| Other Operating Activity | 446,900 | 341,600 | 282,400 | 767,900 | 79,600 |
| Operating Cash Flow | $5,289,800 | $3,216,400 | $1,176,100 | $6,856,800 | $4,628,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 545,000 | 519,000 | 539,000 | -686,500 | -200,600 |
| PPE Investments | -416,100 | -240,400 | -101,400 | -669,700 | -443,400 |
| Net Acquisitions | -307,800 | N/A | N/A | -609,400 | -328,700 |
| Purchase Of Investment | -2,824,300 | -1,801,100 | -238,300 | -1,067,200 | -518,200 |
| Sale Of Investment | 1,082,600 | 435,400 | 211,900 | 584,700 | 444,400 |
| Purchase Sale Intangibles | -605,700 | -432,800 | -29,600 | -442,400 | -419,000 |
| Other Investing Activity | -1,027,000 | -852,200 | -451,900 | -711,700 | -548,800 |
| Investing Cash Flow | $-2,947,600 | $-1,939,300 | $-40,700 | $-3,159,800 | $-1,595,300 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -28,600 | -128,500 | -116,200 | 125,100 | 125,100 |
| Debt Issued | N/A | -54,600 | -54,600 | N/A | 300 |
| Debt Repayment | -54,600 | N/A | N/A | -1,100 | N/A |
| Dividend Paid | -1,636,200 | -1,095,300 | -543,200 | -2,165,300 | -1,621,200 |
| Other Financing Activity | 400 | 300 | 200 | 19,400 | 23,500 |
| Financing Cash Flow | $-1,719,000 | $-1,278,100 | $-713,800 | $-2,021,900 | $-1,472,300 |
| Exchange Rate Effect | -18,700 | 121,300 | 91,600 | -144,800 | -115,200 |
| Beginning Cash Position | 5,993,200 | 5,993,200 | 5,993,200 | 4,462,900 | 4,462,900 |
| End Cash Position | 6,597,700 | 6,113,500 | 6,506,400 | 5,993,200 | 5,908,800 |
| Net Cash Flow | $604,500 | $120,300 | $513,200 | $1,530,300 | $1,445,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,289,800 | 3,216,400 | 1,176,100 | 6,856,800 | 4,628,700 |
| Capital Expenditure | -416,100 | -240,400 | -101,400 | -694,300 | -443,400 |
| Free Cash Flow | 4,873,700 | 2,976,000 | 1,074,700 | 6,162,500 | 4,185,300 |